Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MYM Nutraceuticals Inc MYMMF

MYM Nutraceuticals Inc is a Canada based company engaged in the business of acquiring and developing natural remedies. The company is focused on the medical marijuana business by producing cannabis growing facilities and products.

GREY:MYMMF - Post Discussion

MYM Nutraceuticals Inc > BioHemp rescission agreement
View:
Post by jjeerryy on Oct 03, 2019 8:42am

BioHemp rescission agreement

VANCOUVER, British ColumbiaOct. 3, 2019 /CNW/ -- MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) ("MYM" or the "Company") provides an update on the BioHemp Naturals Growing and Farming Ltd. ("BioHemp") rescission agreement announced August 24, 2019.

The Company is proceeding as planned with the application for an order for rescission. We anticipate that the Department of Justice, on behalf of its government clients, will not oppose the application and we expect that the order for rescission will be granted in the next few weeks.

Once the order for rescission is granted, the transaction between MYM and BioHemp which closed on August 1, 2019 will be treated as if it never occurred. In keeping with this, the purchase price of $2.5 million and 6,000,000 million shares of MYM will be returned to MYM and MYM will return the shares of BioHemp.

Comment by cashmoneyboys88 on Oct 03, 2019 10:26am
A step in the right direction. $2.5 million back in the kitty along with 6,000,000 million shares less dilution. Hopefully some positive news soon on license. GLTA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities